033270.KS
Korea United Pharm Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 18,470.00
+1.15%Margins
Gross margin
59.0%
EBITDA margin
21.8%
EBIT margin
16.5%
Net margin
25.6%
FCF margin
13.9%
15.3%
Return on equity
13.3%
Return on assets
9.6%
Return on invested capital
0.53x
Asset turnover
KRW 83.9B
Cash from operations
KRW 11.2K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026